Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.

Powers RW, Jeyabalan A, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units Network.

PLoS One. 2010 Oct 11;5(10):e13263. doi: 10.1371/journal.pone.0013263.

2.

Gestational angiogenic biomarker patterns in high risk preeclampsia groups.

Maynard SE, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Moore Simas TA.

Am J Obstet Gynecol. 2013 Jul;209(1):53.e1-9. doi: 10.1016/j.ajog.2013.03.017. Epub 2013 Mar 18.

PMID:
23517919
3.

Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.

Govender N, Naicker T, Rajakumar A, Moodley J.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):100-5. doi: 10.1016/j.ejogrb.2013.05.021. Epub 2013 Jun 24.

PMID:
23806447
4.

Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.

Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Usui R, Suzuki M.

Hypertens Pregnancy. 2009 Feb;28(1):95-108. doi: 10.1080/10641950802419895.

PMID:
19165674
5.

Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.

Moore Simas TA, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Maynard SE.

J Matern Fetal Neonatal Med. 2014 Jul;27(10):1038-48. doi: 10.3109/14767058.2013.847415. Epub 2013 Oct 29.

PMID:
24066977
6.

Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.

Leaños-Miranda A, Campos-Galicia I, Berumen-Lechuga MG, Molina-Pérez CJ, García-Paleta Y, Isordia-Salas I, Ramírez-Valenzuela KL.

J Rheumatol. 2015 Jul;42(7):1141-9. doi: 10.3899/jrheum.141571. Epub 2015 May 15.

PMID:
25979720
7.

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA; CPEP Study Group.

N Engl J Med. 2006 Sep 7;355(10):992-1005. Erratum in: N Engl J Med. 2006 Oct 26;355(17):1840.

8.

Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.

Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, Bossuyt PM, van der Post JA, von Dadelszen P, Mol BW, Pajkrt E; EBM CONNECT Collaboration.

BJOG. 2012 Jun;119(7):778-87. doi: 10.1111/j.1471-0528.2012.03311.x. Epub 2012 Mar 20. Review.

9.

Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.

Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE.

Am J Obstet Gynecol. 2016 Jan;214(1):108.e1-108.e14. doi: 10.1016/j.ajog.2015.09.066. Epub 2015 Sep 29.

10.

Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.

Chaiworapongsa T, Romero R, Korzeniewski SJ, Kusanovic JP, Soto E, Lam J, Dong Z, Than NG, Yeo L, Hernandez-Andrade E, Conde-Agudelo A, Hassan SS.

Am J Obstet Gynecol. 2013 Apr;208(4):287.e1-287.e15. doi: 10.1016/j.ajog.2013.01.016. Epub 2013 Jan 17.

11.

Soluble endoglin for the prediction of preeclampsia in a high risk cohort.

Maynard SE, Moore Simas TA, Bur L, Crawford SL, Solitro MJ, Meyer BA.

Hypertens Pregnancy. 2010;29(3):330-41. doi: 10.3109/10641950902968684.

PMID:
20670156
12.

Plasma concentrations of soluble endoglin versus standard evaluation in patients with suspected preeclampsia.

Rana S, Cerdeira AS, Wenger J, Salahuddin S, Lim KH, Ralston SJ, Thadhani RI, Karumanchi SA.

PLoS One. 2012;7(10):e48259. doi: 10.1371/journal.pone.0048259. Epub 2012 Oct 26.

13.

Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies.

Staff AC, Harsem NK, Braekke K, Hyer M, Hoover RN, Troisi R.

Eur J Obstet Gynecol Reprod Biol. 2009 Mar;143(1):29-33. doi: 10.1016/j.ejogrb.2008.11.003. Epub 2009 Jan 8.

PMID:
19135290
14.
15.

Angiogenic factors for the prediction of preeclampsia in high-risk women.

Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE.

Am J Obstet Gynecol. 2007 Sep;197(3):244.e1-8.

PMID:
17826405
16.

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde-Agudelo A, Hassan SS.

J Matern Fetal Neonatal Med. 2009 Nov;22(11):1021-38. doi: 10.3109/14767050902994754.

17.

The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.

Aggarwal PK, Chandel N, Jain V, Jha V.

J Hum Hypertens. 2012 Apr;26(4):236-41. doi: 10.1038/jhh.2011.29. Epub 2011 Mar 31.

PMID:
21451568
18.

Effect of smoking on circulating angiogenic factors in high risk pregnancies.

Jeyabalan A, Powers RW, Clifton RG, Van Dorsten P, Hauth JC, Klebanoff MA, Lindheimer MD, Sibai B, Landon M, Miodovnik M; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

PLoS One. 2010 Oct 12;5(10):e13270. doi: 10.1371/journal.pone.0013270.

19.

First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.

Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV.

Am J Obstet Gynecol. 2008 Sep;199(3):266.e1-6. doi: 10.1016/j.ajog.2008.06.069.

PMID:
18771978
20.

Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.

Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM.

Obstet Gynecol. 2008 Jun;111(6):1403-9. doi: 10.1097/AOG.0b013e3181719b7a. Erratum in: Obstet Gynecol. 2008 Sep;112(3):710.

PMID:
18515525

Supplemental Content

Support Center